Nanjing, China

Changchang Kong

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nanjing Southern Element Biotechnology Co., Ltd.. Active years: 2026.


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Changchang Kong: Innovator in Biotechnology

Introduction

Changchang Kong is a notable inventor based in Nanjing, China. He has made significant contributions to the field of biotechnology, particularly through his innovative research and development efforts. His work focuses on the creation of novel biotechnological solutions that have practical applications in various industries.

Latest Patents

Changchang Kong holds a patent for a unique invention titled "Paenibacillus Strain, and Hemostatic Polysaccharide Produced by Same and Use Thereof." This patent highlights his expertise in developing biotechnological products that can be utilized for hemostatic purposes. He has 1 patent to his name, showcasing his commitment to advancing the field.

Career Highlights

Currently, Changchang Kong is associated with Nanjing Southern Element Biotechnology Co., Ltd. His role in the company allows him to collaborate with other talented professionals in the biotechnology sector. His work is characterized by a strong focus on innovation and practical applications of his research.

Collaborations

Changchang Kong has worked alongside notable colleagues, including Jianfa Zhang and Shijunyin Chen. These collaborations have further enriched his research and contributed to the development of groundbreaking biotechnological solutions.

Conclusion

Changchang Kong is a prominent figure in the biotechnology industry, with a focus on innovative solutions that address real-world challenges. His contributions through patents and collaborations reflect his dedication to advancing the field of biotechnology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…